| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |